Browse by UCL people
Group by: Type | Date
Number of items: 78.
Article
Abeysekera, Kushala WM;
Srivastava, Ankur;
Rowe, Ian;
Jarvis, Helen;
Ryder, Stephen D;
Yeoman, Andrew;
Dillon, John F;
(2023)
Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveys.
Frontline Gastroenterology
10.1136/flgastro-2023-102415.
(In press).
|
|
Amin, OE;
Colbeck, EJ;
Daffis, S;
Khan, S;
Ramakrishnan, D;
Pattabiraman, D;
Chu, R;
... Pallett, LJ; + view all
(2020)
Therapeutic potential of TLR8 agonist GS-9688 (selgantolimod) in chronic hepatitis B: re-modelling of antiviral and regulatory mediators.
Hepatology
, 74
(1)
pp. 55-71.
10.1002/hep.31695.
|
|
Asad, H;
Collins, IJ;
Goodall, RL;
Crichton, S;
Hill, T;
Doerholt, K;
Foster, C;
... Collaborative HIV Paediatric Study (CHIPS) Steering Committee, t; + view all
(2021)
Mortality and AIDS-defining events among young people following transition from paediatric to adult HIV care in the UK.
HIV Medicine
10.1111/hiv.13096.
(In press).
|
 |
|
Bandula, S;
Punwani, S;
Rosenberg, WM;
Jalan, R;
Hall, AR;
Dhillon, A;
Moon, JC;
(2015)
Equilibrium Contrast-enhanced CT Imaging to Evaluate Hepatic Fibrosis: Initial Validation by Comparison with Histopathologic Sampling.
Radiology
, 275
(1)
136 - 143.
10.1148/radiol.14141435.
|
|
Bláha, BAF;
Morris, SA;
Ogonah, OW;
Crescente, V;
Rosenberg, W;
Maucourant, S;
Mukhopadhyay, TK;
(2018)
Development of a high-throughput microscale cell disruption platform for Pichia pastoris in rapid bioprocess design.
Biotechnology Progress
, 34
(1)
pp. 130-140.
10.1002/btpr.2555.
|
|
Bossen, L;
Vesterhus, M;
Hov, JR;
Färkkilä, M;
Rosenberg, WM;
Møller, HJ;
Boberg, KM;
... Grønbæk, H; + view all
(2021)
Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis.
Clinical and Translational Gastroenterology
, 12
(3)
, Article e00315. 10.14309/ctg.0000000000000315.
(In press).
|
|
|
Boyd, A;
Srivastava, A;
Rosenberg, W;
Newsome, PN;
Armstrong, MJ;
(2021)
Optimising referral pathways for patients with non-alcoholic fatty liver disease in the UK.
British Journal of Health Care Management
, 27
(3)
pp. 62-70.
10.12968/bjhc.2020.0164.
|
|
Brennan, Paul N;
Tavabie, Oliver D;
Li, Wenhao;
Marjot, Thomas;
Corless, Lynsey;
Fallowfield, Jonathan A;
Jarvis, Helen;
... Abeysekera, Kushala WM; + view all
(2024)
Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice.
The Lancet Gastroenterology & Hepatology
, 9
(6)
pp. 577-582.
10.1016/S2468-1253(23)00453-3.
|
|
Cieply, L;
Simmons, R;
Ijaz, S;
Kara, E;
Rodger, A;
Rosenberg, W;
McGuinness, A;
... Mandal, S; + view all
(2019)
Seroprevalence of HCV, HBV and HIV in two inner-city London Emergency Departments.
Epidemiology & Infection
, 147
, Article e145. 10.1017/S0950268819000360.
|
|
|
Cococcia, Sara;
Dutta, Priti;
Moghim, Melika;
Hogan, Brian;
Tanwar, Sudeep;
Marshall, Aileen;
Macdonald, Douglas;
... Trembling, Paul M; + view all
(2022)
The fate of indeterminate liver lesions: What proportion are precursors of hepatocellular carcinoma?
BMC Gastroenterology
, 22
(1)
, Article 118. 10.1186/s12876-022-02135-x.
|
|
Colant, N;
Melinek, B;
Frank, S;
Rosenberg, W;
Bracewell, DG;
(2021)
Escherichia Coli-Based Cell-Free Protein Synthesis for Iterative Design of Tandem-Core Virus-Like Particles.
Vaccines
, 9
(3)
, Article 193. 10.3390/vaccines9030193.
|
|
|
Colant, N;
Melinek, B;
Teneb, J;
Goldrick, S;
Rosenberg, W;
Frank, S;
Bracewell, DG;
(2020)
A rational approach to improving titer in Escherichia coli‐based cell‐free protein synthesis reactions.
Biotechnology Progress
, Article e3062. 10.1002/btpr.3062.
(In press).
|
|
|
Connoley, D;
Francis-Graham, S;
Storer, M;
Ekeke, N;
Smith, C;
Macdonald, D;
Rosenberg, W;
(2020)
Detection, stratification, and treatment of hepatitis C positive prisoners in the United Kingdom prison estate: Development of a pathway of care to facilitate the elimination of hepatitis C in a London prison.
Journal of Viral Hepatitis
, 27
(10)
pp. 987-995.
10.1111/jvh.13336.
|
|
Connoley, D;
Patel, PJ;
Hogan, B;
Tanwar, S;
Rhodes, F;
Parkes, J;
Burt, A;
... Rosenberg, W; + view all
(2021)
The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study.
BMC Gastroenterology
, 21
(1)
, Article 268. 10.1186/s12876-021-01795-5.
|
|
|
Crossan, C;
Majumdar, A;
Srivastava, A;
Thorburn, D;
Rosenberg, W;
Pinzani, M;
Longworth, L;
(2019)
Referral pathways for patients with NAFLD based on non-invasive fibrosis tests: diagnostic accuracy and cost analysis.
Liver International
, 39
(11)
pp. 2052-2060.
10.1111/liv.14198.
|
|
D'Ambrosio, R;
Aghemo, A;
Rumi, MG;
Degasperi, E;
Sangiovanni, A;
Maggioni, M;
Fraquelli, M;
... Lampertico, P; + view all
(2018)
Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regression.
Liver International
, 38
(8)
pp. 1459-1467.
10.1111/liv.13707.
|
|
D'Ambrosio, R;
Degasperi, E;
Aghemo, A;
Fraquelli, M;
Lampertico, P;
Rumi, MG;
Facchetti, F;
... Colombo, M; + view all
(2016)
Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon.
PLoS One
, 11
(6)
, Article e0155967. 10.1371/journal.pone.0155967.
|
|
|
Day, J;
Patel, P;
Parkes, J;
Rosenberg, W;
(2019)
Derivation and Performance of Standardized Enhanced Liver Fibrosis (ELF) Test Thresholds for the Detection and Prognosis of Liver Fibrosis.
The Journal of Applied Laboratory Medicine
, 3
(5)
pp. 815-826.
10.1373/jalm.2018.027359.
|
|
Day, JW;
Rosenberg, WM;
(2018)
The enhanced liver fibrosis (ELF) test in diagnosis and management of liver fibrosis.
British Journal of Hospital Medicine
, 79
(12)
pp. 694-699.
10.12968/hmed.2018.79.12.694.
|
|
de Vries, EMG;
Farkkila, M;
Milkiewicz, P;
Hov, JR;
Eksteen, B;
Thorburn, D;
Chazouilleres, O;
... Vesterhus, M; + view all
(2017)
Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
Liver International
, 37
(10)
pp. 1554-1561.
10.1111/liv.13402.
|
|
|
Donnan, PT;
McLernon, D;
Steinke, D;
Ryder, S;
Roderick, P;
Sullivan, FM;
Rosenberg, W;
(2007)
Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE).
BMC Health Services Research
, 7
, Article 54. 10.1186/1472-6963-7-54.
|
  |
|
Etoori, David;
Desai, Monica;
Mandal, Sema;
Rosenberg, William;
Sabin, Caroline A;
(2023)
A scoping review of media campaign strategies used to reach populations living with or at high risk for Hepatitis C in high income countries to inform future national campaigns in the United Kingdom.
BMC Infectious Diseases
, 23
(1)
, Article 629. 10.1186/s12879-023-08603-3.
|
|
|
Filipe, ADS;
Sreenu, V;
Hughes, J;
Aranday-Cortes, E;
Irving, WL;
Foster, GR;
Agarwal, K;
... Thomson, EC; + view all
(2017)
Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries.
Journal of Hepatology
, 67
(6)
pp. 1348-1350.
10.1016/j.jhep.2017.06.035.
|
|
Fossdal, G;
Mjelle, AB;
Wiencke, K;
Bjørk, I;
Gilja, OH;
Folseraas, T;
Karlsen, TH;
... Vesterhus, M; + view all
(2021)
Fluctuating biomarkers in primary sclerosing cholangitis: a longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF.
JHEP Reports
10.1016/j.jhepr.2021.100328.
(In press).
|
|
|
Foster, GR;
Agarwal, K;
Cramp, ME;
Moreea, S;
Barclay, S;
Collier, J;
Brown, AS;
... Haber, B; + view all
(2018)
Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial.
Hepatology
, 67
(6)
pp. 2113-2126.
10.1002/hep.29852.
|
|
Francis-Graham, S;
Ekeke, N;
Nelson, C;
Tin, L;
El Haj, S;
Rhodes, T;
Vindrola, C;
... Rosenberg, W; + view all
(2019)
Understanding how, why, for whom, and under what circumstances opt-out blood-borne virus testing programmes work to increase test engagement and uptake within prison: a rapid-realist review.
BMC Health Services Research
, 19
, Article 152. 10.1186/s12913-019-3970-z.
|
|
|
Gardner, Annelys Roque;
Ma, Yifei;
Bacchetti, Peter;
Price, Jennifer C;
Kuniholm, Mark H;
French, Audrey L;
Gange, Stephen;
... Tien, Phyllis C; + view all
(2023)
Longitudinal Assessment of the Enhanced Liver Fibrosis Score in the Era of Contemporary HIV and Hepatitis C Virus Treatment.
Journal of Infectious Diseases
, 227
(11)
pp. 1274-1281.
10.1093/infdis/jiac315.
|
|
Gawrieh, S;
Harlow, KE;
Pike, F;
Yates, KP;
Wilson, LA;
Cummings, OW;
Rosenberg, WM;
... Molleston, JP; + view all
(2021)
Relationship of Enhanced Liver Fibrosis Score with Pediatric Nonalcoholic Fatty Liver Disease Histology and Response to Vitamin E or Metformin.
Journal of Pediatrics
, 239
161-167.e5.
10.1016/j.jpeds.2021.08.012.
|
|
Gawrieh, S;
Wilson, LA;
Yates, KP;
Cummings, OW;
Vilar-Gomez, E;
Ajmera, V;
Kowdley, K;
... Chalasani, N; + view all
(2021)
Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial.
Hepatology Communications
, 5
(5)
pp. 786-797.
10.1002/hep4.1680.
|
|
|
Hauck, NC;
Kirpach, J;
Kiefer, C;
Farinelle, S;
Maucourant, S;
Morris, SA;
Rosenberg, W;
... Lu, I-N; + view all
(2018)
Applying Unique Molecular Identifiers in Next Generation Sequencing Reveals a Constrained Viral Quasispecies Evolution under Cross-Reactive Antibody Pressure Targeting Long Alpha Helix of Hemagglutinin.
Viruses
, 10
(4)
, Article 148. 10.3390/v10040148.
|
|
Hayward, KL;
McKillen, BJ;
Horsfall, LU;
McIvor, C;
Liew, K;
Sexton, J;
Johnson, AL;
... Powell, EE; + view all
(2022)
Towards collaborative management of nonalcoholic fatty liver disease (TCM-NAFLD): a 'real-world' pathway for fibrosis risk assessment in primary care.
Internal Medicine Journal
, 52
(10)
pp. 1749-1758.
10.1111/imj.15422.
|
|
Huang, W-C;
Easom, NJ;
Tang, X-Z;
Gill, US;
Singh, H;
Robertson, F;
Chang, C;
... Maini, MK; + view all
(2017)
T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System.
Journal of Immunology
, 198
(3)
pp. 1172-1182.
10.4049/jimmunol.1601313.
|
|
Hung, A;
Etoori, D;
Modi, R;
Gee, M;
Rosenberg, W;
(2025)
EXSPECT: ELF Cross-comparison between serum and plasma collection tubes.
Clinica Chimica Acta
, 574
, Article 120332. 10.1016/j.cca.2025.120332.
|
|
Hung, Alexander;
Turner, Charlotte;
Rhodes, Freya;
Ryan, Jennifer;
Rosenberg, William M;
(2025)
Enhanced liver fibrosis test facilitates stratification of people with alcohol use disorder in primary care.
BMJ Open Gastroenterology
, 12
(1)
, Article e001905. 10.1136/bmjgast-2025-001905.
|
|
|
Johnson, PJ;
Berhane, S;
Walker, AJ;
Gordon, FH;
Ryder, SD;
McPherson, S;
Sreedharan, A;
... HCV Research UK; + view all
(2020)
Impact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infection.
Journal of Viral Hepatitis
10.1111/jvh.13408.
(In press).
|
|
|
Kazaks, A;
Lu, I-N;
Farinelle, S;
Ramirez, A;
Crescente, V;
Blaha, B;
Ogonah, O;
... Rosenberg, WM; + view all
(2017)
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.
BMC Biotechnology
, 17
(1)
, Article 79. 10.1186/s12896-017-0396-8.
|
|
|
Macpherson, Iain;
Abeysekera, Kushala WM;
Harris, Rebecca;
Mansour, Dina;
McPherson, Stuart;
Rowe, Ian;
Rosenberg, William;
... Specialist Interest Group, in the Early Detection of Liver Disease; + view all
(2022)
Identification of liver disease: why and how.
Frontline Gastroenterology
, 13
(5)
pp. 367-373.
10.1136/flgastro-2021-101833.
|
|
McLernon, DJ;
Dillon, JF;
Sullivan, FM;
Roderick, P;
Rosenberg, WM;
Ryder, SD;
Donnan, PT;
(2012)
The utility of liver function tests for mortality prediction within one year in primary care using the algorithm for liver function investigations (ALFI).
PLoS One
, 7
(12)
, Article e50965. 10.1371/journal.pone.0050965.
|
|
|
Mecci, AJ;
Kemos, P;
Leen, C;
Lawson, A;
Richardson, P;
Khakoo, SI;
Agarwal, K;
... HCV Research UK; + view all
(2019)
The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis.
Alimentary Pharmacology & Therapeutics
, 50
(2)
pp. 204-214.
10.1111/apt.15296.
|
|
Nebbia, G;
Peppa, D;
Schurich, A;
Khanna, P;
Singh, HD;
Cheng, Y;
Rosenberg, W;
... Maini, MK; + view all
(2012)
Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection.
PLOS One
, 7
(10)
, Article e47648. 10.1371/journal.pone.0047648.
|
|
|
Pang, EL;
Peyret, H;
Ramirez, A;
Loh, H-S;
Lai, K-S;
Fang, C-M;
Rosenberg, WM;
(2019)
Epitope Presentation of Dengue Viral Envelope Glycoprotein Domain III on Hepatitis B Core Protein Virus-Like Particles Produced in Nicotiana benthamiana.
Frontiers in Plant Science
, 10
, Article 455. 10.3389/fpls.2019.00455.
|
|
|
Parkes, J;
Roderick, P;
Bennett-Lloyd, B;
Rosenberg, W;
(2006)
Variation in hepatitis C services may lead to inequity of heath-care provision: a survey of the organisation and delivery of services in the United Kingdom.
BMC Public Health
, 6
, Article 3. 10.1186/1471-2458-6-3.
|
|
|
Patel, P;
Hossain, F;
Horsfall, LU;
Banh, X;
Hayward, KL;
Williams, S;
Johnson, T;
... Powell, EE; + view all
(2018)
A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At-Risk Populations in Primary Care.
Hepatology Communications
, 2
(8)
pp. 893-905.
10.1002/hep4.1208.
|
|
|
Patel, PJ;
Connoley, D;
Rhodes, F;
Srivastava, A;
Rosenberg, W;
(2019)
A review of the clinical utility of the Enhanced Liver Fibrosis test in multiple aetiologies of chronic liver disease.
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
10.1177/0004563219879962.
(In press).
|
|
|
Peveler, WJ;
Landis, RF;
Yazdani, M;
Day, JW;
Modi, R;
Carmalt, CJ;
Rosenberg, WM;
(2018)
A Rapid and Robust Diagnostic for Liver Fibrosis Using a Multichannel Polymer Sensor Array.
Advanced Materials
, 30
(28)
, Article 1800634. 10.1002/adma.201800634.
|
|
|
Polaris Observatory HCV Collaborators;
(2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.
The Lancet Gastroenterology and Hepatology
, 2
(3)
pp. 161-176.
10.1016/S2468-1253(16)30181-9.
|
|
|
Potier, Julie FN;
Durham, Andy E;
Modi, Raakesh;
Rosenberg, William;
Dash, Sophie A;
(2023)
Investigation of Serum Markers of Hepatic Fibrosis in Equids.
Journal of Equine Veterinary Science
, 131
, Article 104937. 10.1016/j.jevs.2023.104937.
|
|
Ramirez, A;
Morris, S;
Maucourant, S;
D'Ascanio, I;
Crescente, V;
Lu, I-N;
Farinelle, S;
... Rosenberg, W; + view all
(2018)
A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
Vaccine
, 36
(6)
pp. 873-880.
10.1016/j.vaccine.2017.12.053.
|
|
Razavi, Homie A;
Buti, Maria;
Terrault, Norah A;
Zeuzem, Stefan;
Yurdaydin, Cihan;
Tanaka, Junko;
Aghemo, Alessio;
... Polaris Observatory, .; + view all
(2023)
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
Journal of Hepatology
10.1016/j.jhep.2023.02.041.
(In press).
|
|
|
Razavi-Shearer, D;
Child, H;
Razavi-Shearer, K;
Voeller, A;
Razavi, H;
Buti, M;
Tacke, F;
... et, alia; + view all
(2023)
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories.
Journal of Hepatology
10.1016/j.jhep.2023.10.043.
(In press).
|
|
Rhodes, FA;
Trembling, P;
Panovska-Griffiths, J;
Tanwar, S;
Westbrook, RH;
Rodger, A;
Rosenberg, WM;
(2021)
Systematic review: Investigating the prognostic performance of four non‐invasive tests in alcohol‐related liver disease.
European Journal of Gastroenterology & Hepatology
, 36
(6)
pp. 1435-1449.
10.1111/jgh.15335.
|
|
Rhodes, F;
Cococcia, S;
Panovska-Griffiths, J;
Tanwar, S;
Westbrook, RH;
Rodger, A;
Rosenberg, WM;
(2021)
Uncovering unsuspected advanced liver fibrosis in patients referred to alcohol nurse specialists using the ELF test.
BMC Gastroenterology
, 21
(1)
, Article 143. 10.1186/s12876-021-01728-2.
|
|
|
Rhodes, FA;
Cococcia, S;
Patel, P;
Panovska-Griffiths, J;
Tanwar, S;
Westbrook, RH;
Rodger, A;
(2021)
Is there scope to improve the selection of patients with alcohol-related liver disease for referral to secondary care? A retrospective analysis of primary care referrals to a UK liver centre, incorporating simple blood tests.
BMJ Open
, 11
(6)
, Article e047786. 10.1136/bmjopen-2020-047786.
|
|
|
Saffioti, F;
Roccarina, D;
Vesterhus, M;
Hov, JR;
Rosenberg, W;
Pinzani, M;
Pereira, SP;
... Thorburn, D; + view all
(2019)
Cholangiocarcinoma is associated with a raised enhanced liver fibrosis (ELF) score independent of primary sclerosing cholangitis.
European Journal of Clinical Investigation
, 49
(5)
, Article e13088. 10.1111/eci.13088.
|
|
Schurich, A;
Pallett, LJ;
Lubowiecki, M;
Singh, HD;
Gill, US;
Kennedy, PT;
Nastouli, E;
... Maini, MK; + view all
(2013)
The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells.
PLoS Pathogens
, 9
(3)
, Article e1003208. 10.1371/journal.ppat.1003208.
|
|
|
Sharma, C;
Cococcia, S;
Ellis, N;
Parkes, J;
Rosenberg, W;
(2021)
Systematic review: Accuracy of The Enhanced Liver Fibrosis Test for diagnosing advanced liver fibrosis and cirrhosis.
Journal of Gastroenterology and Hepatology
10.1111/jgh.15482.
(In press).
|
|
|
Simmons, R;
Ireland, G;
Ijaz, S;
Ramsay, M;
Mandal, S;
Sabin, C;
Nardone, A;
... Rosenberg, W; + view all
(2019)
Causes of death among persons diagnosed with hepatitis C infection in the pre- and post-DAA era in England: A record linkage study.
Journal of Viral Hepatitis
, 26
(7)
pp. 873-880.
10.1111/jvh.13096.
|
|
Singh, HD;
Otano, I;
Rombouts, K;
Singh, KP;
Peppa, D;
Gill, US;
Bottcher, K;
... Maini, MK; + view all
(2017)
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis.
Scientific Reports
, 7
, Article 5514. 10.1038/s41598-017-05845-5.
|
|
|
Srivastava, A;
Gailer, R;
Tanwar, S;
Trembling, P;
Parkes, J;
Rodger, A;
Suri, D;
... Rosenberg, W; + view all
(2019)
Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease.
Journal of Hepatology
10.1016/j.jhep.2019.03.033.
(In press).
|
|
|
Srivastava, A;
Jong, S;
Gola, A;
Gailer, R;
Morgan, S;
Sennett, K;
Tanwar, S;
... Rosenberg, W; + view all
(2019)
Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease.
BMC Gastroenterology
, 19
(1)
, Article 122. 10.1186/s12876-019-1039-4.
|
|
|
Stasi, C;
Tsochatzis, EA;
Hall, A;
Rosenberg, W;
Milani, S;
Dhillon, AP;
Pinzani, M;
(2019)
Comparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver disease.
Digestive and Liver Disease
, 51
(7)
pp. 1001-1007.
10.1016/j.dld.2018.12.005.
|
|
Stejskal, Lenka;
Kalemera, Mphatso D;
Lewis, Charlotte B;
Palor, Machaela;
Walker, Lucas;
Daviter, Tina;
Lees, William D;
... Grove, Joe; + view all
(2022)
An entropic safety catch controls Hepatitis C virus entry and antibody resistance.
eLife
, 11
, Article e71854. 10.7554/eLife.71854.
|
|
Subhani, Mohsan;
Dhanda, Ashwin;
Olaru, Adina;
Dunford, Louise;
Ahmad, Nahid;
Wragg, Andrew;
Frost, Kate;
... Ryder, Stephen D; + view all
(2024)
Top ten research priorities for alcohol use disorder and alcohol-related liver disease: results of a multistakeholder research priority setting partnership.
The Lancet Gastroenterology and Hepatology
, 9
(5)
pp. 400-402.
10.1016/S2468-1253(24)00009-8.
|
|
Swadling, L;
Pallett, LJ;
Diniz, MO;
Baker, JM;
Amin, OE;
Stegmann, KA;
Burton, AR;
... Maini, MK; + view all
(2020)
Human Liver Memory CD8+ T Cells Use Autophagy for Tissue Residence.
Cell Reports
, 30
(3)
687-698.e6.
10.1016/j.celrep.2019.12.050.
|
|
|
Tanwar, S;
Srivastava, A;
Rosenberg, W;
(2020)
Errors in modeling misrepresent the utility of the enhanced liver fibrosis test in the management of non-alcoholic fatty liver disease.
Journal of Hepatology
, 73
(6)
pp. 1580-1581.
10.1016/j.jhep.2020.07.009.
|
|
Tanwar, S;
Rhodes, F;
Srivastava, A;
Trembling, PM;
Rosenberg, WM;
(2020)
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C.
World Journal of Gastroenterology
, 26
(2)
pp. 109-133.
10.3748/wjg.v26.i2.109.
|
|
|
Tanwar, S;
Trembling, PM;
Hogan, BJ;
Parkes, J;
Harris, S;
Grant, P;
Nastouli, E;
... Rosenberg, WM; + view all
(2017)
Biomarkers of Hepatic Fibrosis in Chronic Hepatitis C A Comparison of 10 Biomarkers Using 2 Different Assays for Hyaluronic Acid.
Journal of Clinical Gastroenterology
, 51
(3)
pp. 268-277.
10.1097/MCG.0000000000000581.
|
|
|
Tanwar, S;
Trembling, PM;
Hogan, BJ;
Srivastava, A;
Parkes, J;
Harris, S;
Grant, P;
... Rosenberg, WM; + view all
(2017)
Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.
European Journal of Gastroenterology & Hepatology
, 29
(3)
pp. 289-296.
10.1097/MEG.0000000000000789.
|
|
Trembling, PM;
Apostolidou, S;
Gentry-Maharaj, A;
Parkes, J;
Ryan, A;
Tanwar, S;
Burnell, M;
... Rosenberg, WM; + view all
(2020)
The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease.
BMC Gastroenterology
, 20
(1)
, Article 104. 10.1186/s12876-020-01251-w.
|
|
|
Trembling, PM;
Apostolidou, S;
Gentry-Maharaj, A;
Parkes, J;
Ryan, A;
Tanwar, S;
Burnell, M;
... Rosenberg, WM; + view all
(2017)
Risk of chronic liver disease in post-menopausal women due to body mass index, alcohol and their interaction: a prospective nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
BMC Public Health
, 17
(1)
, Article 603. 10.1186/s12889-017-4518-y.
|
|
Trembling, PM;
Apostolidou, S;
Gentry-Maharaj, A;
Parkes, J;
Ryan, A;
Tanwar, S;
Burnell, M;
... Rosenberg, WM; + view all
(2018)
Association between skirt size and chronic liver disease in post-menopausal women: a prospective cohort study within the United Kingdom Trial of Ovarian Cancer Screening (UKCTOCS).
BMC Public Health
, 18
, Article 409. 10.1186/s12889-018-5308-x.
|
|
|
Trembling, PM;
Tanwar, S;
Rosenberg, WM;
Lampertico, P;
Viganò, M;
Facchetti, F;
Colombo, M;
(2014)
Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection.
Journal of Viral Hepatitis
, 21
(6)
430 - 438.
10.1111/jvh.12161.
|
|
|
Tsochatzis, EA;
Srivastava, A;
Rosenberg, W;
(2020)
Reply to: "FIB-4 cut off of 1.3 may be inappropriate in a primary care referral pathway for patients with non-alcoholic fatty liver disease".
Journal of Hepatology
, 73
(1)
pp. 217-218.
10.1016/j.jhep.2020.02.016.
|
|
Vergis, Nikhil;
Patel, Vishal;
Bogdanowicz, Karolina;
Czyzewska-Khan, Justyna;
Keshinro, Rosemary;
Fiorentino, Francesca;
Day, Emily;
... Thursz, Mark; + view all
(2025)
IL-1 Signal Inhibition in Alcohol-Related Hepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial of Canakinumab.
Clinical Gastroenterology and Hepatology
, 23
(5)
797-807.e5.
10.1016/j.cgh.2024.07.025.
|
|
Wahl, K;
Rosenberg, W;
Vaske, B;
Manns, MP;
Schulze-Osthoff, K;
Bahr, MJ;
Bantel, H;
(2012)
Biopsy-controlled liver fibrosis staging using the enhanced liver fibrosis (ELF) score compared to transient elastography.
PLoS One
, 7
(12)
, Article e51906. 10.1371/journal.pone.0051906.
|
|
Proceedings paper
|
Subhani, Mohsan;
Dhanda, Ashwin;
Olaru, Adina;
Dunford, Louise;
Ahmad, Nahid;
Wragg, Andrew;
Adams, Julie;
... Ryder, Stephen; + view all
(2024)
Top 10 research priorities for alcohol use disorder and alcohol-related liver disease results of a multi-stakeholder research priority setting partnership.
In:
Gut.
(pp. A14-A15).
BMJ
|
Conference item
|
Tanwar, Sudeep;
Gregory, Walter;
Selby, Peter;
Rosenberg, William;
(2024)
Predicting liver related morbidity and mortality in non-cirrhotic chronic liver disease: early results from the ELUCIDATE trial.
Presented at: Abstracts of the British Association for the Study of the Liver Annual Meeting.
|
Thesis
|
Macdonald, D;
(2014)
Lentiviral vector vaccines for T cell-mediated protection against influenza.
Doctoral thesis , UCL (University College London).
|
|
